Flash Finance

Niva Bupa Health Insurance Company LimitedNIVABUPACorporate

Finance & Investments Latest results: Jun 2026 12 quarters of data
₹75.96
MCap ₹14,050 Cr · P/E 39.0
Niva Bupa Health Insurance Company Limited — Stock analysis & AI research Niva Bupa Health Insurance Company Limited — Seasonality — best & worst months Niva Bupa Health Insurance Company Limited — Technical indicators & charts Niva Bupa Health Insurance Company Limited — Technical setup — score, trend, support & resistance Niva Bupa Health Insurance Company Limited — Falling Wedge pattern forming Niva Bupa Health Insurance Company Limited — Live exchange announcements
📋 High Sales Growth Stocks📋 High Profit Growth Stocks📋 Stocks With Strong Quarterly Results📋 Small Cap Stocks List 🏭 Financial Services sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹2,274 Cr
Sales · Jun 2026
+65.8% YoY
₹101 Cr
Operating Profit · Jun 2026
+208.5% YoY
4.4%
OPM % · Jun 2026
+164.7% YoY
₹138 Cr
Net Profit · Jun 2026
+251.4% YoY
₹0.75
EPS · Jun 2026
+250.0% YoY

📝 Niva Bupa Health Insurance Company Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Niva Bupa Health Insurance Company Limited reported revenue of ₹2,274 crore for the quarter ended June 2026 (Q1 FY27), up 65.8% from ₹1,371 crore in the same quarter last year, and up 6.3% sequentially over the March 2026 quarter.

The company swung to a net profit of ₹138 crore from a net loss of ₹91 crore a year earlier. Earnings per share (EPS) came in at ₹0.75.

Operating profit stood at ₹101 crore — an operating margin (OPM) of 4.4%, compared with -6.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Niva Bupa Health Insurance Company Limited posted revenue of ₹6,695 crore, a growth of 24.6% over FY25, with a net profit of ₹131 crore (down 38.5% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹7,598 crore with a net profit of ₹360 crore.

Valuation snapshot

At the current price of ₹75.96, NIVABUPA has a market capitalisation of ₹14,050 crore and a trailing P/E of about 39.0.

Within the Finance & Investments industry, it is the 11th-largest of the 117 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 55.30%, foreign institutional investors (FIIs) 12.09%, domestic institutional investors (DIIs) 16.17%, public shareholders 16.44% of Niva Bupa Health Insurance Company Limited.

Promoter holding slipped from 55.36% to 55.30% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹14,050 Cr
Current Price ?
₹76.0
P/E ?
39.05above ind
Industry P/E ?
18.90
P/B ?
3.71
P/S ?
1.85
P/FCF ?
16.39
Enterprise Value ?
₹14,300 Cr
EV/EBITDA ?
44.84
PEG ?
0.31
Earnings Yield ?
1.5%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹7,598 Cr
OPM ?
4.2%
Profit after tax (TTM) ?
₹360 Cr
EPS (TTM) ?
₹1.95
ROCE ?
3.0%
ROE ?
9.5%
ROA ?
3.0%
Growth
Sales — latest qtr ?
₹2,274 Cr
PAT — latest qtr ?
₹138 Cr
YoY qtr sales growth ?
65.8%
YoY qtr profit growth ?
251.4%
Sales growth (3y) ?
33%
Sales growth (5y) ?
36%
Profit growth (3y) ?
127%
Profit growth (5y) ?
36%
Financial Health
Debt ?
₹250 Cr
Debt to Equity ?
0.07
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
55.30%
Change in promoter holding ?
-0.13%
Pledged percentage ?
N/A
Market
Return 3 months ?
-11.7%
Return 6 months ?
-5.2%

🗓️ Quarterly results (12 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 9691,0261,3161,1241,3211,2581,6711,3711,5741,6112,1392,274 +65.8% +6.3%
Operating Profit -58-46100-103-66-24251-93-53-94365101 +208.5% -72.4%
Other Income 505057847937-452187-24198 +9801.5% +925.1%
Interest 000000000009 — —
Depreciation 00000000000106 — —
Profit Before Tax -85157-191313206-91-35-88341184 +301.9% -46.1%
Net Profit -85157-191313206-91-35-88345138 +251.4% -60.1%
EPS —————0.071.13-0.50-0.19-0.471.870.75 +250.0% -59.9%
OPM % -6.0% -4.5% 7.6% -9.2% -5.0% -1.9% 15.0% -6.8% -3.4% -5.8% 17.1% 4.4% +164.7% -74.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹5,374 Cr ₹6,695 Cr ₹7,598 Cr +24.6%
Operating Profit ₹58 Cr ₹125 Cr ₹319 Cr +115.5%
OPM % 1.08% 1.87% 4.20% +73.1%
NPM % 3.96% 1.96% 4.74% -50.5%
Other Income ₹155 Cr ₹3 Cr ₹199 Cr -98.1%
Depreciation ₹0 Cr ₹0 Cr ₹106 Cr —
Interest ₹0 Cr ₹0 Cr ₹9 Cr —
EBIT ₹58 Cr ₹125 Cr ₹213 Cr +115.5%
PBT ₹213 Cr ₹127 Cr ₹402 Cr -40.4%
Tax — — ₹46 Cr —
Net Profit ₹213 Cr ₹131 Cr ₹360 Cr -38.5%
EPS ₹1.20 ₹0.71 ₹1.96 -40.8%
Material Cost — — — —
Employee Cost — — ₹199 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 1,5111,7001,8271,847 +1.1%
Reserves -6833511,2311,939 +57.5%
Borrowings 250250250250 +0.0%
Other Liabilities 2,7993,8916,4527,827 +21.3%
Total Liabilities 3,8776,1929,76011,864 +21.6%
Fixed Assets 52586688 +33.3%
CWIP 4190 -100.0%
Investments 3,3665,4588,1759,670 +18.3%
Other Assets 4556751,5102,106 +39.5%
Total Assets 3,8776,1929,76011,864 +21.6%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 5938131,654905 -45.3%
Cash from Investing Activity -829-1,882-2,348-961 +59.1%
Cash from Financing Activity 2801,110771-5 -100.6%
Net Cash Flow 434178-62 -179.5%
Free Cash Flow 5557801,613857 -46.9%
CFO/OP -180%-720%2,121%725% -65.8%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 0000 —
Cash Conversion Cycle 0000 —
Working Capital Days -313-298-351-322 +8.3%
ROCE % 1%5%7%3% -57.1%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 55.43%55.41%55.36%55.36%55.30% -0.1%
FIIs 10.76%10.72%10.31%10.60%12.09% +14.1%
DIIs 15.06%15.31%16.04%16.49%16.17% -1.9%
Public 18.74%18.57%18.27%17.56%16.44% -6.4%
No. of Shareholders 1,54,8831,58,5501,47,7181,35,3431,26,567 -6.5%

⚖️ Peer comparison

Industry: Finance & Investments · top 25 of 117 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 LICI Life Insurance ₹398.20 503,723 8.4 881,845 60,055 -7.5% 6.8% 10.0% 18.9% -43.2% 24.0%
2 SBILIFE SBI Life ₹1,671.70 167,740 67.9 112,315 2,471 0.7% 2.2% -3.9% 2.4% -82.4% -1.1%
3 ICICIGI ICICI Lombard ₹1,508.90 75,386 29.5 27,196 2,556 5.4% 9.4% 12.7% 10.6% -3.2% 15.4%
4 ICICIPRULI ICICI Prudential ₹496.90 72,089 44.8 63,356 1,608 0.3% 2.5% -10.5% 35.7% -79.7% 62.1%
5 GICRE General Insurance ₹337.75 59,255 6.7 51,723 8,877 16.9% 17.2% 6.8% 30.0% -8.6% -31.1%
6 MFSL Max Financial ₹1,585.90 54,444 492.4 49,823 137 0.5% 0.3% 2.6% -73.9% 16.7% 37.5%
7 STARHEALTH Star Health ₹555.55 32,689 38.7 18,509 844 4.4% 4.6% 10.7% -13.8% 16.2% 109.0%
8 NIACL New India ₹171.56 28,273 36.7 49,363 771 -1.3% 1.6% 14.3% 36.4% -3.6% -160.7%
9 GODIGIT Go Digit ₹250.90 23,196 47.1 10,128 492 0.7% 4.9% 6.8% 28.0% 5.5% -37.4%
10 FIVESTAR Five-Star Business ₹549.40 16,218 14.7 3,293 1,103 11.0% 33.5% 13.3% 2.3% 5.9% 2.0%
11 NIVABUPA Niva Bupa ₹74.77 13,830 38.1 7,598 360 4.2% 4.7% 24.6% -38.5% 65.8% 251.4%
12 PRUDENT Prudent Corporate ₹3,123.30 12,933 52.8 1,372 246 24.2% 17.9% 19.5% 13.8% 18.2% 43.8%
13 EDELWEISS Edelweiss Financial ₹126.74 11,996 17.1 10,508 711 27.5% 6.8% 12.5% 27.1% 3.7% 30.5%
14 IIFLCAPS IIFL Capital ₹344.80 10,867 18.8 2,433 572 35.0% 23.5% 0.6% -20.8% 2.3% 4.6%
15 SBFC SBFC Finance ₹87.70 9,745 20.1 1,783 480 9.8% 26.9% 28.6% 30.7% 26.7% 28.8%
16 RELIGARE Religare Enterprises ₹223.35 7,700 n/m 8,953 18 0.7% 0.2% 14.8% -60.3% 26.5% -687.3%
17 PAISALO Paisalo Digital ₹76.83 7,023 29.4 943 237 0.0% 25.1% 22.0% 19.1% 33.8% 56.5%
18 FEDFINA Fedbank Financial ₹150.76 5,655 12.9 2,563 434 12.9% 16.9% 7.1% 52.2% 34.3% 63.4%
19 MASFIN MAS Financial ₹288.85 5,241 13.3 2,092 398 7.1% 19.0% 24.8% 19.4% 20.3% 26.6%
20 NORTHARC Northern Arc ₹301.00 4,865 12.0 2,705 404 0.0% 14.9% 14.8% 34.2% 22.7% 250.0%
21 PILANIINVS Pilani Investment ₹4,020.00 4,451 — 248 -12 87.1% -4.9% -6.4% -68.5% -70.9% -1075.5%
22 SHAREINDIA Share India ₹183.78 4,022 11.1 1,577 364 40.1% 23.1% 1.5% -1.2% 31.4% 48.1%
23 KIRLOSIND Kirloskar Industries ₹3,690.00 3,878 50.6 113 76 71.5% 67.0% 9.0% -2.1% -27.9% -9.4%
24 INDOSTAR IndoStar Capital ₹239.15 3,866 — 1,417 -395 6.6% -27.8% 74.4% 15.7% -76.0% -97.9%
25 MUTHOOTMF Muthoot Microfin ₹179.17 3,006 12.5 2,493 245 4.3% 9.8% -7.1% 176.6% 20.0% 1250.0%
❓ Frequently asked questions
What was Niva Bupa Health Insurance Company Limited's revenue in Q1 FY27?
Niva Bupa Health Insurance Company Limited reported revenue of ₹2,274 crore for the quarter ended June 2026 (Q1 FY27), up 65.8% from ₹1,371 crore in the same quarter last year, and up 6.3% sequentially over the March 2026 quarter.
What was Niva Bupa Health Insurance Company Limited's net profit in Q1 FY27?
The company swung to a net profit of ₹138 crore from a net loss of ₹91 crore a year earlier. Earnings per share (EPS) came in at ₹0.75.
What is NIVABUPA's market capitalisation and P/E ratio?
At the current price of ₹75.96, NIVABUPA has a market capitalisation of ₹14,050 crore and a trailing P/E of about 39.0.
Who owns Niva Bupa Health Insurance Company Limited? (shareholding pattern)
As of Jun 2026, promoters held 55.30%, foreign institutional investors (FIIs) 12.09%, domestic institutional investors (DIIs) 16.17%, public shareholders 16.44% of Niva Bupa Health Insurance Company Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI